PFE - Pfizer Inc. Stock Price and Quote

PFE [NYSE]

Healthcare | Drug Manufacturers - General | USA

Index	S&P 500	P/E	7.46	EPS (ttm)	5.47	Insider Own	0.04%	Shs Outstand	5.61B	Perf Week	2.38%
Market Cap	230.86B	Forward P/E	10.80	EPS next Y	3.78	Insider Trans	-0.50%	Shs Float	5.61B	Perf Month	-4.98%
Income	31.37B	PEG	-	EPS next Q	0.99	Inst Own	70.50%	Short Float / Ratio	0.69% / 1.70	Perf Quarter	-23.88%
Sales	100.33B	P/S	2.30	EPS this Y	39.30%	Inst Trans	0.53%	Short Interest	38.49M	Perf Half Y	-11.34%
Book/sh	17.04	P/B	2.39	EPS next Y	12.30%	ROA	16.30%	Target Price	51.68	Perf Year	-24.76%
Cash/sh	4.02	P/C	10.16	EPS next 5Y	-5.45%	ROE	35.10%	52W Range	39.23 - 56.32	Perf YTD	-20.36%
Dividend	1.64	P/FCF	13.54	EPS past 5Y	22.70%	ROI	25.30%	52W High	-27.54%	Beta	0.62
Dividend %	4.02%	Quick Ratio	1.00	Sales past 5Y	13.80%	Gross Margin	65.50%	52W Low	4.03%	ATR	0.83
Employees	83000	Current Ratio	1.20	Sales Q/Q	2.80%	Oper. Margin	36.40%	RSI (14)	43.37	Volatility	2.11% 1.89%
Optionable	Yes	Debt/Eq	0.37	EPS Q/Q	30.10%	Profit Margin	31.30%	Rel Volume	0.00	Prev Close	40.81
Shortable	Yes	LT Debt/Eq	0.34	Earnings	Jan 31 BMO	Payout	28.60%	Avg Volume	22.63M	Price	40.81
Recom	2.50	SMA20	0.25%	SMA50	-5.70%	SMA200	-13.69%	Volume	0	Change	0.00%

Mar-06-23

Initiated

Jefferies

Hold

$43

Feb-07-23

Upgrade

Daiwa Securities

Neutral → Outperform

$51

Jan-26-23

Downgrade

UBS

Buy → Neutral

$55 → $47

Jan-17-23

Downgrade

Wells Fargo

Overweight → Equal Weight

$54 → $50

Jan-04-23

Downgrade

BofA Securities

Buy → Neutral

$60

Dec-13-22

Upgrade

Goldman

Neutral → Buy

$47 → $60

Nov-18-22

Initiated

Credit Suisse

Outperform

$55

May-23-22

Initiated

SVB Leerink

Mkt Perform

$55

Apr-06-22

Resumed

Morgan Stanley

Equal-Weight

$55

Jan-05-22

Upgrade

BofA Securities

Neutral → Buy

$59 → $70

Show Previous Ratings

Mar-20-23 06:33PM	UPDATE 1-Moderna expects to price its COVID vaccine at about $130 in the US Reuters
05:57PM	Moderna expects to price its COVID vaccine at about $130 in the US Reuters
05:45PM	Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know Zacks
08:30AM	2 Undervalued Stocks to Buy Today to Prepare for the Next Bull Market Motley Fool
Mar-19-23 09:15AM	1 Top Healthcare Stock That Could Make You Richer in the Next Decade Motley Fool
06:43AM	Loading…
06:43AM	5 big deal reports: UBS offers to snap up Credit Suisse for $1 billion \| Pro Recap Investing.com
Mar-18-23 06:29PM	Why Nick Jonas is raising awareness for diabetes at SXSW Yahoo Finance Video
Mar-17-23 04:41PM	Seagen and Newell Brands Stock See Action From Activist Investors Barrons.com
12:19PM	Pfizer's (PFE) COVID-19 Drug Paxlovid Gets FDA Panel Vote Zacks
12:18PM	WHO expects to declare end to pandemic sometime in 2023 as virus becomes more like seasonal flu MarketWatch
12:17PM	Pfizer, Astellas Tout Positive Xtandi Data To Potentially Expand Label For The Prostate Cancer Drug Benzinga
11:04AM	FDA Advisory Committee Votes Favoring Pfizer's COVID-19 Pill Paxlovid Benzinga
10:11AM	Pfizer Working To Develop New Packaging For Migraine Drug Over Child Safety, Poisoning Concerns Benzinga
10:08AM	Pharma Stock Roundup: M&A Boom in Drug Industry With PFE & SNY Deals, Other Updates Zacks
08:45AM	Better RSV Vaccine Stock: Pfizer, GSK, or Moderna? Motley Fool
07:30PM	Loading…
Mar-16-23 07:30PM	Phase 3 Study Shows XTANDI® (enzalutamide) plus Leuprolide Significantly Improves Metastasis-Free Survival in Men with Non-Metastatic Prostate Cancer PR Newswire
04:30PM	COVID-19 pill Paxlovid moves closer to full FDA approval AP Finance
03:18PM	FDA Advisory Committee Votes in Support of Favorable Benefit-Risk Profile for Pfizers PAXLOVID Business Wire
03:16PM	FDA committee says benefits outweigh risks for Pfizers Paxlovid MarketWatch
11:20AM	Biotech Stock Roundup: ACAD's Drug Approval, SGEN to be Acquired by PFE & More Zacks
09:53AM	This Must-Buy Dividend Growth Stock Could Pay You for Life Motley Fool
09:52AM	UPDATE 2-Pfizer to replace migraine drug packaging over child safety concerns Reuters
09:40AM	Is Pfizer Stock A Buy Or A Sell On Its Looming $43 Billion Seagen Takeover? Investor's Business Daily
09:33AM	UPDATE 3-FDA advisers back Pfizer's COVID treatment for full approval Reuters
08:35AM	FDA panel to meet Thursday to discuss full approval of Paxlovid MarketWatch
05:52AM	Here's Why Pfizer Stock Is Looking Increasingly Attractive Motley Fool
Mar-15-23 03:38PM	Medicare identifies drug makers that will owe penalties for raising prices on 27 drugs faster than rate of inflation Yahoo Finance
02:38PM	Pfizer (PFE) Gets FDA Nod for Bivalent COVID Jab in Infants Zacks
10:21AM	FDA Approves Pfizer/BioNTech's Bivalent COVID-19 Vaccine For Youngest Kids Benzinga
09:19AM	Company News for Mar 15, 2023 Zacks
08:39AM	Loading…
08:39AM	FDA updates authorization of BioNTech, Pfizers bivalent booster for young children MarketWatch
04:54AM	6 big analyst cuts: Norfolk Southern stock slashed on Ohio derailments \| Pro Recap Investing.com
Mar-14-23 10:20PM	25 Biggest Pharmaceutical Companies in the World Insider Monkey
07:01PM	U.S. FDA expands authorization of Pfizer bivalent COVID-19 shots in kids Reuters
05:45PM	Pfizer (PFE) Gains But Lags Market: What You Should Know Zacks
04:48PM	Data For Pfizer's COVID-19 Drug Shows No Possible Association With Infection Rebound Benzinga
03:14PM	UPDATE 2-Pfizer agrees to revise EU COVID vaccine contract -FT Reuters
03:14PM	Should Investors Consider Pfizer (PFE) or Seagen (SGEN) Stock After Acquisition Zacks
02:29PM	Pfizers revised EU Covid vaccine contract meets resistance Financial Times
02:00PM	Does This Billion-Dollar Deal Solve Pfizer's Biggest Problem? Motley Fool
12:42PM	15 Best 52-Week Low Stocks To Buy Now Insider Monkey
11:45AM	Is Pfizer Stock a Screaming Buy After Its $43 Billion Seagen Acquisition? Motley Fool
10:24AM	Pfizer (PFE) to Buy Seagen for $43B, Boost Cancer Portfolio Zacks
09:39AM	UPDATE 4-Pfizer's COVID drug data supports use in high-risk patients - FDA staff Reuters
09:24AM	Company News for Mar 14, 2023 Zacks
09:06AM	Seagen (SGEN) Set to be Acquired by Pfizer for $43 B, Stock Up Zacks
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It Zacks
04:53AM	Strength Seen in Seattle Genetics (SGEN): Can Its 14.5% Jump Turn into More Strength? Zacks
12:54AM	PRESS DIGEST- Wall Street Journal - March 14 Reuters
Mar-13-23 07:30PM	Astellas Announces Phase 3 China ARCHES Study of XTANDI® Meets Primary Endpoint PR Newswire
07:15PM	Monday Merger Mania Just Made These 2 Biotech Stocks Big Winners Motley Fool
04:10PM	Seagen Nabs $43 Billion Pfizer Deal; Sanofi Scoops Up Provention Bio Investor's Business Daily
04:08PM	Week Ahead: Banking Crisis, Inflation Reports, and Big Pharma Acquisitions Zacks
03:18PM	Best-Selling Drugs by Bristol Myers, Pfizer, AbbVie Likely Candidates For US Price Negotiation Benzinga
03:06PM	Pfizer Agrees to Buy Seagen for $43 Billion The Wall Street Journal
02:36PM	Pfizers $43 billion bid for Seagen aims to broaden companys cancer portfolio MarketWatch
02:20PM	Pfizer is buying a cancer biotech in one of the biggest pharma deals in history Quartz
01:37PM	Pfizer Overpays for Seagen, but Whos Counting The Wall Street Journal
01:16PM	Pfizer to Pay $43 Billion for Seagen, Set Post-Covid Course Bloomberg
12:25PM	Pfizer/Seagen: post-Covid growth does not come cheaply Financial Times
12:14PM	Pfizer Agrees to Buy Cancer Drug Maker Seagen for $43 Billion Investopedia
12:06PM	Pfizer to battle cancer with Seagen merger, CEO Albert Bourla says Yahoo Finance Video
11:48AM	Why Seagen Stock Is Soaring Today Motley Fool
11:39AM	Pfizer (PFE) Gets FDA Nod for Migraine Nasal Spray Zavzpret Zacks
11:09AM	Seagen's $43B Deal To Double Pfizer's Early-Stage Oncology Pipeline, Seagen Says Is Right Step Benzinga
10:19AM	Pfizer aiming to acquire Seagen in $43 billion deal Yahoo Finance Video
10:07AM	Pfizer Rolls the Dice on Seagen in $43 Billion Deal. The Risks It Faces. Barrons.com
09:17AM	Pfizer Officially Nabs Seagen For $43 Billion; Provention Soars On Sanofi Deal Investor's Business Daily
07:31AM	Pfizer to buy oncology-focused biotech Seagen for $43bn Financial Times
07:31AM	Pfizer set to buy oncology-focused biotech SeaGen in $43bn deal Financial Times
07:19AM	Pfizer to Buy Cancer Biotech Seagen for $43 Billion Barrons.com
07:08AM	Pfizer buys Seagen for $43B, boosts access to cancer drugs AP Finance
07:04AM	Pfizer to purchase Seagen in $43 billion all-cash deal, cancer biotechs stock pops 20% MarketWatch
06:54AM	Pfizer signs $43 billion Seagen deal in cancer drug push Reuters
06:45AM	Pfizer Invests $43 Billion to Battle Cancer Business Wire
06:08AM	Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation Reuters
06:00AM	Bristol Myers, Pfizer, AbbVie drugs likely to face U.S. price negotiation Reuters
Mar-11-23 06:14AM	3 No-Brainer Dividend Stocks to Buy in March Motley Fool
Mar-10-23 10:52AM	FDA Approves Pfizer's Fast Acting Migraine Drug Acquired Via $11B Biohaven Acquisition Benzinga
10:29AM	BioNTech (BNTX) to Report Q4 Earnings: What's in the Cards? Zacks
07:05AM	UPDATE 4-US FDA approves Pfizer's nasal spray for migraine Reuters
06:54AM	Pfizer wins FDA approval for its migraine nasal spray MarketWatch
06:45AM	Pfizers ZAVZPRET (zavegepant) Migraine Nasal Spray Receives FDA Approval Business Wire
06:28AM	3 Market-Neutral Funds to Counter Market Volatility Zacks
Mar-09-23 09:37AM	Pfizer Is Targeting an Acquisition That Could Be a Game Changer for Its Business Motley Fool
06:51AM	UPDATE 2-Pfizer ready to launch RSV vaccines for older adults, pregnant women in US, Europe Reuters
04:56AM	UPDATE 1-GSK expects US launch of RSV vaccine with no supply issues Reuters
03:00AM	GSK set for US launch of RSV vaccine with no supply issues Reuters
Mar-08-23 05:45PM	Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know Zacks
08:15AM	Sanofi, AstraZeneca Tee Up A Rival To Pfizer In The Multibillion-Dollar RSV Race Investor's Business Daily
08:13AM	Six Flags and Equinox Gold have been highlighted as Zacks Bull and Bear of the Day Zacks
05:30AM	Big Companies Seeing Tax Benefits From Law Change Some of Them Fought The Wall Street Journal
03:03AM	Q4 2022 Voyager Therapeutics Inc Earnings Call Thomson Reuters StreetEvents
Mar-07-23 11:00AM	Lilly's (LLY) Verzenio Gets FDA Nod for Expanded Breast Cancer Zacks
10:33AM	Pfizer (PFE) or GSK: Who Will Get the First FDA Nod for RSV Jab? Zacks
08:02AM	UPDATE 1-Britons aged over 75 to be offered COVID-19 booster shot in spring Reuters
06:11AM	20 Most Important Companies in the World Insider Monkey
Mar-06-23 12:29PM	Seagens Cancer Therapy Is Making It a Takeover Target The Wall Street Journal
08:00AM	Why Big Drugmakers Want to Buy Cancer Biotech Seagen The Wall Street Journal
Mar-05-23 08:30AM	Could This Be the Next Blockbuster Vaccine for This Big Pharma Stock? Motley Fool

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DAMICO JENNIFER B.	SVP & Controller	Mar 15	Sale	40.02	9,912	396,678	9,003	Mar 17 04:53 PM
SUSMAN SALLY	Executive Vice President	Feb 25	Option Exercise	22.89	72,984	1,670,604	209,179	Feb 28 05:52 PM
JOHNSON RADY A	Executive Vice President	Feb 25	Option Exercise	22.89	33,654	770,340	116,473	Feb 28 05:52 PM
Hwang Angela	President, Global Biopharma	Feb 25	Option Exercise	22.89	20,273	464,049	44,541	Feb 28 05:52 PM
McDermott Michael	Executive Vice President	Feb 25	Option Exercise	22.89	14,178	324,534	93,099	Feb 28 05:52 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 25	Option Exercise	22.89	11,150	255,224	27,893	Feb 28 05:52 PM
SUSMAN SALLY	Executive Vice President	Feb 22	Option Exercise	30.17	76,043	2,294,217	195,493	Feb 24 09:17 PM
Hwang Angela	President, Global Biopharmaceu	Feb 22	Option Exercise	30.17	57,032	1,720,655	67,027	Feb 24 09:34 PM
JOHNSON RADY A	Executive Vice President	Feb 22	Option Exercise	30.17	31,558	952,105	106,556	Feb 24 08:27 PM
SAHNI PAYAL	Executive Vice President	Feb 22	Option Exercise	30.17	15,209	458,856	32,671	Feb 24 09:03 PM
McDermott Michael	Executive Vice President	Feb 22	Option Exercise	30.17	13,307	401,472	88,957	Feb 24 08:52 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22	Option Exercise	30.17	10,456	315,458	21,584	Feb 24 08:14 PM
BOURLA ALBERT	Chairman & CEO	Dec 16	Option Exercise	27.25	222,328	6,058,580	411,890	Dec 16 06:14 PM
LANKLER DOUGLAS M	Executive Vice President	Dec 14	Option Exercise	26.29	101,658	2,672,548	180,461	Dec 16 06:14 PM
Dolsten Mikael	President R&D	Nov 07	Option Exercise	33.21	79,108	2,627,260	420,007	Nov 09 04:08 PM
DAMICO JENNIFER B.	SVP & Controller	Jun 07	Sale	53.96	4,218	227,603	10,846	Jun 08 04:43 PM
DAMICO JENNIFER B.	SVP & Controller	May 16	Sale	50.50	4,000	202,000	15,064	May 17 07:48 AM
SAHNI PAYAL	Executive Vice President	May 13	Sale	49.84	1,408	70,175	17,372	May 16 09:23 PM
LANKLER DOUGLAS M	Executive Vice President	May 12	Sale	49.41	38,273	1,891,069	78,803	May 13 05:19 PM
Carapezzi William R JR	Executive Vice President	May 12	Sale	50.00	32,908	1,645,400	38,146	May 13 05:38 PM
Dolsten Mikael	President R&D	May 11	Sale	49.32	63,902	3,151,547	333,342	May 12 04:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Upgrade your FINVIZ experience